Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipid peroxidation products are a diverse group of molecules generated during the oxidative degradation of lipids, particularly polyunsaturated fatty acids (PUFAs), in biological membranes. This process is initiated by reactive oxygen species (ROS) or free radicals and results in primary products like lipid hydroperoxides (LOOH) and secondary products like malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE). These products can modify proteins and DNA, contributing to cellular dysfunction and various diseases, including cancer, atherosclerosis, and neurodegenerative disorders.
N/A
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipid Peroxidation Product.